Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JANET PAN

NPI
1801056676
CMS profile
354136
Location
FOUNTAIN VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$6,939.00

351 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $6,819.00 349
Education $120.00 2

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Janssen Biotech, Inc. $481.87 21
Novartis Pharmaceuticals Corporation $455.97 21
Incyte Corporation $405.02 17
AstraZeneca Pharmaceuticals LP $388.33 18
Merck Sharp & Dohme LLC $334.08 16
PFIZER INC. $293.83 16
Celgene Corporation $280.88 23
Seagen Inc. $273.90 13
Bayer Healthcare Pharmaceuticals Inc. $255.26 17
Takeda Pharmaceuticals U.S.A., Inc. $243.40 10
Eisai Inc. $194.57 9
E.R. Squibb & Sons, L.L.C. $183.03 20
Puma Biotechnology, Inc. $167.48 7
Karyopharm Therapeutics Inc. $161.65 7
Regeneron Healthcare Solutions, Inc. $150.70 6
Amgen Inc. $146.90 9
Gilead Sciences, Inc. $145.29 7
Daiichi Sankyo Inc. $133.30 6
Sumitomo Pharma America, Inc. $133.18 10
Genentech USA, Inc. $130.01 6
Exelixis Inc. $118.96 4
Stemline Therapeutics Inc. $116.81 5
Astellas Pharma US Inc $113.82 5
ABBVIE INC. $110.60 4
Pharmacyclics LLC, An AbbVie Company $104.39 5
Blueprint Medicines Corporation $98.67 3
ImmunoGen, Inc. $94.89 4
AVEO Pharmaceuticals, Inc. $94.72 4
GlaxoSmithKline, LLC. $91.21 4
Kite Pharma, Inc. $82.74 4
MorphoSys, US Inc. $78.25 4
TAIHO ONCOLOGY, INC. $72.84 4
GENZYME CORPORATION $72.52 4
Coherus Biosciences Inc. $71.85 4
BeiGene USA, Inc. $70.75 3
ARRAY BIOPHARMA INC $59.85 5
Rigel Pharmaceuticals, Inc. $56.81 3
Agios Pharmaceuticals, Inc. $51.30 2
Alexion Pharmaceuticals, Inc. $48.95 2
Adaptive Biotechnologies Corporation $43.13 2
Ipsen Biopharmaceuticals, Inc $38.97 2
Boehringer Ingelheim Pharmaceuticals, Inc. $37.11 2
EMD Serono, Inc. $31.33 2
Grifols USA, LLC $29.06 1
Genmab U.S., Inc. $27.07 1
Amneal Pharmaceuticals LLC $26.56 1
Deciphera Pharmaceuticals Inc. $25.56 1
Mirati Therapeutics, Inc. $21.00 1
CSL Behring $17.19 1
SOBI, INC $16.75 1
ADC Therapeutics America, Inc. $16.51 1
Octapharma USA, Inc. $13.86 1
SERVIER PHARMACEUTICALS LLC $13.44 1
Telix Pharmaceuticals $12.88 1

Page 5 of 8; records 201–250 of 351 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JANET PAN

NPI 1801056676 · CMS profile ID 354136

FOUNTAIN VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 5 of 8; records 201–250 of 351 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1801056676?year=2023&recipient=provider&page=5#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JANET PAN, NPI 1801056676, CMS profile ID 354136. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 8; records 201–250 of 351 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1801056676?year=2023&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). JANET PAN, NPI 1801056676, CMS profile ID 354136. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 8; records 201–250 of 351 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1801056676?year=2023&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
JANET PAN, NPI 1801056676, CMS profile ID 354136, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 5 of 8; records 201–250 of 351 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1801056676?year=2023&recipient=provider&page=5#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

351 matching records · $6,939.00 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 351 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 201–250 of 351.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
MorphoSys, US Inc. $22.3105/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060328617 CMS
SOBI, INC $16.7505/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038094801 CMS
Celgene Corporation $6.9805/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015742419 CMS
Novartis Pharmaceuticals Corporation $24.7905/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992865743 CMS
AstraZeneca Pharmaceuticals LP $23.9105/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014902917 CMS
Incyte Corporation $27.7705/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044572513 CMS
Telix Pharmaceuticals $12.8805/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1005801511 CMS
Celgene Corporation $4.9905/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015742399 CMS
Celgene Corporation $5.1005/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015742403 CMS
E.R. Squibb & Sons, L.L.C. $0.2205/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015742411 CMS
E.R. Squibb & Sons, L.L.C. $17.1505/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015742415 CMS
Incyte Corporation $14.9805/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044572701 CMS
Janssen Biotech, Inc. $16.7305/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988660971 CMS
PFIZER INC. $17.6505/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049390485 CMS
E.R. Squibb & Sons, L.L.C. $0.2705/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015742387 CMS
E.R. Squibb & Sons, L.L.C. $15.5005/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015742391 CMS
Merck Sharp & Dohme LLC $25.1705/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048382243 CMS
GlaxoSmithKline, LLC. $27.6005/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002556031 CMS
Eisai Inc. $21.0305/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023313819 CMS
Karyopharm Therapeutics Inc. $24.1505/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056902273 CMS
AstraZeneca Pharmaceuticals LP $20.3305/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016069539 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.5705/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000302855 CMS
Bayer Healthcare Pharmaceuticals Inc. $28.4205/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000374501 CMS
PFIZER INC. $27.5305/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050290447 CMS
Stemline Therapeutics Inc. $17.0605/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040028037 CMS
Rigel Pharmaceuticals, Inc. $19.4605/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1033381993 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.1605/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996559807 CMS
Kite Pharma, Inc. $23.5205/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025272255 CMS
Merck Sharp & Dohme LLC $11.0405/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048382247 CMS
Amgen Inc. $18.1105/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019951647 CMS
Sumitomo Pharma America, Inc. $13.6505/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1030814745 CMS
Janssen Biotech, Inc. $15.2605/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988660985 CMS
Janssen Biotech, Inc. $21.0805/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988660987 CMS
MorphoSys, US Inc. $24.4905/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060328615 CMS
Bayer Healthcare Pharmaceuticals Inc. $7.8704/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000222025 CMS
BeiGene USA, Inc. $18.7404/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051194465 CMS
Kite Pharma, Inc. $20.1904/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025272253 CMS
Merck Sharp & Dohme LLC $26.3704/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048382205 CMS
Regeneron Healthcare Solutions, Inc. $23.2004/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999347329 CMS
Seagen Inc. $19.5104/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995665035 CMS
Genentech USA, Inc. $27.2804/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040388369 CMS
Celgene Corporation $25.8704/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015742371 CMS
Celgene Corporation $4.4204/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015742375 CMS
Alexion Pharmaceuticals, Inc. $22.7704/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017085261 CMS
Regeneron Healthcare Solutions, Inc. $22.1404/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999347317 CMS
Regeneron Healthcare Solutions, Inc. $11.8404/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999347323 CMS
TAIHO ONCOLOGY, INC. $15.2104/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055229837 CMS
Adaptive Biotechnologies Corporation $21.4604/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022973099 CMS
Novartis Pharmaceuticals Corporation $32.4804/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992865727 CMS
PFIZER INC. $17.7804/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049514955 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,304.61 322
PY2020 $5,339.64 303
PY2021 $6,218.12 325
PY2022 $6,396.31 346
PY2023 $6,939.00 351
PY2024 $7,888.97 348
PY2025 $8,105.08 333

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $96,505.50 3
PY2024 Principal investigator $13,150.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $14,535.50 11/20/2025 Non-covered Recipient Entity
Los Angeles Cancer Network
A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) No dispute reported 06/30/2026 1235996173
Principal investigator 1 Celgene Corporation $55,585.00 06/25/2025 Non-covered Recipient Entity
Los Angeles Cancer Network
A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) No dispute reported 06/30/2026 1222306877
Principal investigator 1 Celgene Corporation $26,385.00 04/23/2025 Non-covered Recipient Entity
Los Angeles Cancer Network
A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) No dispute reported 06/30/2026 1222306937